Bright Minds Biosciences (DRUG) Accounts Payables (2020 - 2026)

For the quarter ending Q1 2026, Accounts Payables rose 3438.07% year-over-year to $2.7 million, compared with a TTM value of $2.7 million through Mar 2026, up 3438.07%, and an annual FY2025 reading of $1.6 million, up 447.45% over the prior year.

Bright Minds Biosciences (DRUG) has disclosed Accounts Payables for 6 consecutive years, with $2.7 million as the latest value for Q1 2026.

  • Accounts Payables reached $2.7 million in Q1 2026 per DRUG's latest filing, up from $1.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.7 million in Q1 2026 and bottomed at $77299.9 in Q1 2025.
  • Average Accounts Payables over 5 years is $996349.8, with a median of $687848.2 recorded in 2024.
  • Year-over-year, Accounts Payables tumbled 85.64% in 2023 and then skyrocketed 3438.07% in 2026.
  • Bright Minds Biosciences' Accounts Payables stood at $1.1 million in 2022, then plummeted by 85.64% to $154636.6 in 2023, then surged by 93.2% to $298754.5 in 2024, then skyrocketed by 447.45% to $1.6 million in 2025, then skyrocketed by 67.22% to $2.7 million in 2026.
  • Per Business Quant, the three most recent readings for DRUG's Accounts Payables are $2.7 million (Q1 2026), $1.6 million (Q3 2025), and $77299.9 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1.05 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 10.62 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 489.30 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 1.03 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 126.63 Mn
10 Bright Minds Biosciences 464.72 Mn 405.19 Mn - 2.73 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.73 Mn
Dec 31, 2025 1.07 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 380,200.31
Mar 31, 2025 390,423.76
Dec 31, 2024 -43,267.35
Sep 30, 2024 298,754.45
Jun 30, 2024 -31,216.05
Mar 31, 2024 448,049.37
Dec 31, 2023 435,058.05
Sep 30, 2023 154,636.61
Jun 30, 2023 566,645.20
Mar 31, 2023 -349,404.45
Dec 31, 2022 -697,200.19
Sep 30, 2022 1.08 Mn
Jun 30, 2022 198,633.49
Mar 31, 2022 288,112.73
Dec 31, 2021 118,188.83
Sep 30, 2021 507,288.34
Jun 30, 2021 147,034.46
Mar 31, 2021 203,500.30
Dec 31, 2020 25,914.94
Sep 30, 2020 113,256.19